Definitive Healthcare Corp (DH, Financial) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $61.72 million, and the earnings are expected to come in at $0.04 per share. The full year 2024's revenue is expected to be $249.23 million and the earnings are expected to be -$1.52 per share. More detailed estimate data can be found on the Forecast page.
Definitive Healthcare Corp (DH, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Definitive Healthcare Corp (DH) have declined from $250.55 million to $249.23 million for the full year 2024, and from $258 million to $254.55 million for 2025. Earnings estimates have also seen changes; for the full year 2024, estimates declined from -$1.18 per share to -$1.52 per share, while for 2025, estimates increased from -$0.32 per share to -$0.17 per share.
Definitive Healthcare Corp (DH, Financial) Reported History
In the previous quarter of 2024-06-30, Definitive Healthcare Corp's (DH) actual revenue was $63.74 million, which beat analysts' revenue expectations of $63.2 million by 0.85%. Definitive Healthcare Corp's (DH) actual earnings were -$1.81 per share, which missed analysts' earnings expectations of -$0.414 per share by -337.2%. After releasing the results, Definitive Healthcare Corp (DH) was up by 2.82% in one day.
Definitive Healthcare Corp (DH, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 9 analysts, the average target price for Definitive Healthcare Corp (DH) is $5.61 with a high estimate of $7.50 and a low estimate of $4.00. The average target implies an upside of 36.19% from the current price of $4.12.
Based on GuruFocus estimates, the estimated GF Value for Definitive Healthcare Corp (DH, Financial) in one year is $11.36, suggesting an upside of 175.73% from the current price of $4.12.
Based on the consensus recommendation from 13 brokerage firms, Definitive Healthcare Corp's (DH, Financial) average brokerage recommendation is currently 2.5, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
